Market Flash

DIC Corporation announced that its subsidiary Ideal Chemi Plast Pvt. Ltd. has opened a new production plant at Supa Japan Industrial Area, Maharashtra on February 15, 2024.

• DIC
• Ideal Chemi Plast
• coating resins

Ascentage Pharma, a leading biopharmaceutical company, has announced its plans to present three groundbreaking clinical advancements at the American Association for Cancer Research (AACR) Annual Meeting in 2024.

Y-mAbs, a commercial-stage biopharmaceutical company specializing in the development and commercialization of novel antibody-based cancer therapeutics, has announced the appointment of Dr. Mary Tagliaferri to its Board of Directors.

In the highly competitive landscape of the pharmaceutical industry, even the giants can stumble. When discussing the most challenging times for multinational pharmaceutical companies in recent years.

The intersection of artificial intelligence (AI) and the pharmaceutical industry has been a topic of extensive discussion and debate. While some skeptics view it as a dead-end, others see it as a disruptive force that can revolutionize drug development.

The Australian Pesticide and Veterinary Medicine Authority (APVMA) recently issued an official bulletin, APVMA intends to approve BASF (Australia) company's application for Glufosinate-P (ammonium salt) as an active ingredient in agricultural chemicals.

• Glufosinate-P
• Glufosinate
• ammonium
• salt

In a shocking revelation, the global food industry has been hit by a major scandal as counterfeit olive oil floods the market.

Ensuring food safety is of paramount importance in today's world. As consumers, we rely on the food industry to provide us with safe and nutritious products.

In a concerning development, China's export of peanuts has once again come under scrutiny due to elevated levels of aflatoxins.

In a recent development, China's exported cumin powder has been flagged for containing excessive pesticide residue.

In a recent development, China's export of rice noodles has been brought under scrutiny due to the detection of unauthorized genetically modified (GM) ingredients.

In a significant milestone for Henlius, the pharmaceutical company has announced its first-ever annual profit, surpassing 500 million yuan.

In a stunning move, GinkgoBioworks, a synthetic biology giant, has recently announced the acquisition of two AI-driven pharmaceutical startups, ReverieLabs and PatchBiosciences, along with an RNA platform company, ProofDiagnostics.

In a significant milestone for Akeso Inc., the company has announced its first annual profit, surpassing 1.85 billion yuan.

ARLANXEO recently announced a new hydrogenated nitrile rubber plant in Changzhou, China. The plant has a designed annual production capacity of approximately 5,000 tons.

• ARLANXEO
• Therban®
• synthetic rubber

Clinical Skin announced on March 4 the acquisition of skin care brand Glytone from French pharmaceutical and cosmetics company Pierre Fabre Laboratories. The financial terms of the transaction were not disclosed.

• Clinical Skin
• Glytone

Recently, Canada’s Pest Management Regulatory Agency (PMRA) has approved the sale and use of Diflufenican and its formulation products SC500, SC600 and SC617, providing Canadian farmers with more efficient weed control options.

• Diflufenican
• Isoxaflutole
• Metribuzin

In recent years, telemedicine has emerged as a game-changer in the field of healthcare.

In the world of antisense oligonucleotide (ASO) drugs, China is eagerly awaiting the development of its first domestically produced ASO medication.

In recent developments, Sanofi has registered a Phase 2 open-label, long-term study on the Chinese Clinical Trial Registry platform.